Home/BioGaia/Zlatko Rihter
ZR

Zlatko Rihter

Chief Financial Officer

BioGaia

BioGaia Pipeline

DrugIndicationPhase
L. reuteri DSM 17938 (Protectis®)Infant Colic & Functional GI DisordersPhase 4
L. reuteri ATCC PTA 6475 (Prodentis®)Periodontal Health (Gingivitis)Phase 3
L. reuteri Gastrus®Adult Irritable Bowel Syndrome (IBS)Phase 3
L. reuteri ATCC PTA 6475 (Osfortis®)Bone Health (Postmenopausal Osteopenia)Phase 2
L. reuteri DSM 17938 (Aldermis®)Atopic Dermatitis in InfantsPhase 2
L. reuteri Immune ActiveImmune Support & Respiratory InfectionsPhase 2/3